MDS Latest News
The Independent supplement on Blood disorders – published on the 2nd September (not the 30th Aug as initially planned).
Read full storyJoin the newly formed Cambridge Regional Group – contact us for details – and get a chance to meet-up every 3-4 months. Read more.
Read full storyThe latest newsletter is now ready to view by clicking on the image
The Spring 2011 newsletter is now ready to view on the information material pagehere.
Read full storyThe MDS UK Patient Support Group today expressed its anger and disappointment at the announcement by the Scottish Medicines Consortium that is not recommending Vidaza (azacitidine) be made available through NHS Scotland to patients with a range of life-threatening bone marrow diseases.
Read full story'Cancer experts from more than 30 hospitals across Europe have joined a campaign to get an expensive life-extending drug on the NHS', writes Daily Telegraph's medical correspondent Kate Devlin.
Read full storyLondon, 26 July 2010 – The MDS UK Patient Support Group has welcomed the decision announced today by the National Institute for Health and Clinical Excellence (NICE) that it will re-appraise the use of Vidaza (azacitidine)in patients with higher-risk myelodysplastic syndrome (MDS)- a group of debilitating bone marrow diseases.
Read full storyThe MDS UK Patient Support Group has announced that it has lodged an appeal against the negative recommendation issued earlier this month by the National Institute for Health and Clinical Excellence (NICE) for the use of Vidaza (azacitidine) in patients with higher-risk myelodysplastic syndrome (MDS).
Read full storyOnly 200 patients helped by £50m fund for extra cancer drugs
Read full storyLatest update on how the Interim Cancer Drug Fund will be implemented at your local Strategic Health Authority level.
Read full story